Daniel Chen, M.D. Ph.D.

Dr. Daniel Chen, a multi-talented individual holding both M.D. and Ph.D. degrees, is a renowned figure in the field of Cancer Immunotherapy. He is the co-author of significant works like 'The cancer-immunity cycle' (Immunity 2013) and 'the cancer-immune set point' (Nature 2017) with Ira Mellman. Dr. Chen is a forward-thinker who envisions the future of medicine through the integration of engineering, science, and medicine. With a robust background in drug development spanning pre-clinical to Phase I-IV, he excels in Oncology, Immunology, Virology, Filings, Biomarkers, and Organizational Leadership. He is an alum of prestigious institutions such as Stanford University School of Medicine, University of Southern California, and Massachusetts Institute of Technology. Dr. Chen has held pivotal roles at esteemed organizations like the Society for Immunotherapy of Cancer (SITC), IGM Biosciences, and Genentech, demonstrating his expertise and strategic acumen in the industry.